Cathie's Ark Logo
undefined Logo

ARKK Holdings of Verve Therapeutics (VERV) - Updated Daily

Gene TherapyGenomicsCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
July 15, 2024
SELL127.000ARKK
July 12, 2024
SELL2.188k0.0002%ARKK
July 10, 2024
SELL52.937k0.0054%ARKK
July 9, 2024
SELL64.879k0.006%ARKK
July 8, 2024
SELL9.984k0.0009%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0%$389.27m
🏋🏿‍♂️Weight Rank In ARKK🌏Country
32🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
160$28.17
🎫ARK Ownership Percent
0%

Other ETFs That Hold VERV

Ticker
NameWeight
ARKGARK Genomic Revolution ETF2.46%
GNOMGlobal X Genomics & Biotechnology ETF1.1%
XBISPDR® S&P Biotech ETF0.82%
ARKKARK Innovation ETF0.36%
LABUS&P Biotech Bull 3X Shares ETF0.124%
IBBiShares Biotechnology ETF0.07%

Research Notes and Commentary for VERV

No Research Notes Found for VERV